FLAVONE

FLAVONE is a lipid of Polyketides (PK) class. Flavone is associated with abnormalities such as Cardiovascular Diseases, Cerebrovascular accident, DERMATITIS HERPETIFORMIS, FAMILIAL, Hyperinsulinism and Inflammatory disorder. The involved functions are known as Oxidation-Reduction, Metabolic Inhibition, Inflammation, Phosphorylation and antioxidant activity. Flavone often locates in Endothelium, Hepatic, Protoplasm, Body tissue and Extracellular. The associated genes with FLAVONE are ICAM1 gene, BCL2L1 gene, MYC gene, TP53 gene and cytochrome c''. The related lipids are Promega, Steroids and Total cholesterol. The related experimental models are Knock-out, Disease model and Animal Disease Models.

Cross Reference

Introduction

To understand associated biological information of FLAVONE, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with FLAVONE?

FLAVONE is suspected in Diabetes Mellitus, Non-Insulin-Dependent, Obesity, Chronic Disease, Disintegration, Cardiovascular Diseases, Cerebrovascular accident and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with FLAVONE

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Stomach Ulcer D013276 75 associated lipids
Diabetes Mellitus D003920 90 associated lipids
Neoplasms, Experimental D009374 10 associated lipids
Adenocarcinoma D000230 166 associated lipids
Dermatitis, Contact D003877 59 associated lipids
Pain D010146 64 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lung Neoplasms D008175 171 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Per page 10 20 50 | Total 32

PubChem Associated disorders and diseases

What pathways are associated with FLAVONE

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with FLAVONE?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with FLAVONE?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with FLAVONE?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with FLAVONE?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with FLAVONE?

Knock-out

Knock-out are used in the study 'MATE2 mediates vacuolar sequestration of flavonoid glycosides and glycoside malonates in Medicago truncatula.' (Zhao J et al., 2011) and Knock-out are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Disease model

Disease model are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Animal Disease Models

Animal Disease Models are used in the study 'How can research on plants contribute to promoting human health?' (Martin C et al., 2011).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with FLAVONE

Download all related citations
Per page 10 20 50 100 | Total 1492
Authors Title Published Journal PubMed Link
Bourdillat B et al. Mechanism of action of hispidulin, a natural flavone, on human platelets. 1988 Prog. Clin. Biol. Res. pmid:2845433
Urba WJ et al. Enhancement of natural killer activity in human peripheral blood by flavone acetic acid. 1988 J. Natl. Cancer Inst. pmid:2452890
Hornung RL et al. Augmentation of natural killer activity, induction of IFN and development tumor immunity during the successful treatment of established murine renal cancer using flavone acetic acid and IL-2. 1988 J. Immunol. pmid:2460546
Verweij J et al. Rapid alkalinisation for flavone acetic acid administration: a potentially hazardous procedure. 1988 Lancet pmid:2893206
Davis HP et al. Immune thrombocytopenia caused by flavone-8-acetic acid. 1988 Lancet pmid:2893207
Yamazoe Y et al. Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450. 1988 Carcinogenesis pmid:3121205
Yamazoe Y et al. Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-488-H type cytochrome P-450. 1988 Jpn. J. Cancer Res. pmid:3147272
Armand J et al. Flavonoids: a new class of anticancer agents? Preclinical and clinical data of flavone acetic acid. 1988 Prog. Clin. Biol. Res. pmid:3051027
Pratesi G et al. Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512). 1988 Br. J. Cancer pmid:3166904
Bibby MC et al. Experimental anti-tumor effects of flavone acetic acid (LM975). 1988 Prog. Clin. Biol. Res. pmid:3174695
Bibby MC et al. Unique chemosensitivity of MAC 16 tumours to flavone acetic acid (LM975, NSC 347512). 1988 Br. J. Cancer pmid:3179187
Ching LM and Baguley BC Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512). 1988 Eur J Cancer Clin Oncol pmid:3181272
Damia G et al. Dose-dependent pharmacokinetics of flavone acetic acid in mice. 1988 Cancer Chemother. Pharmacol. pmid:3396145
Evelhoch JL et al. Flavone acetic acid (NSC 347512)-induced modulation of murine tumor physiology monitored by in vivo nuclear magnetic resonance spectroscopy. 1988 Cancer Res. pmid:3409216
Gouyette A et al. Flavone acetic acid: a nonlinear pharmacokinetic model. 1988 Cancer Chemother. Pharmacol. pmid:3409441
Abdalla S et al. Effects of hispidulin, a flavone isolated from Inula viscosa, on isolated guinea-pig smooth muscle. 1988 Gen. Pharmacol. pmid:3410278
Hornung RL et al. Immunomodulation of natural killer cell activity by flavone acetic acid: occurrence via induction of interferon alpha/beta. 1988 J. Natl. Cancer Inst. pmid:3418728
Oberpichler H et al. Effects of Ginkgo biloba constituents related to protection against brain damage caused by hypoxia. 1988 Pharmacol Res Commun pmid:3420139
Bissery MC et al. Flavone acetic acid (NSC 347512)-induced DNA damage in Glasgow osteogenic sarcoma in vivo. 1988 Cancer Res. pmid:3422592
Finlay GJ et al. Effect of flavone acetic acid on Lewis lung carcinoma: evidence for an indirect effect. 1988 J. Natl. Cancer Inst. pmid:3351960
Giavazzi R et al. Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts. 1988 Br. J. Cancer pmid:3355765
Gachályi A et al. Mobilization of 85Sr by flavone derivatives (morin and ipriflavone) in normal and pregnant rats. 1988 Radiobiol Radiother (Berl) pmid:3186955
Chen JC et al. [Anti-arrhythmic action of 4'-methyl-7-([2-hydroxy-3-(beta-propinamidoethyl)amino]propoxy) flavone hydrochloride (SIPI-644)]. 1988 Zhongguo Yao Li Xue Bao pmid:3188948
Fisher RF et al. Specific binding of proteins from Rhizobium meliloti cell-free extracts containing NodD to DNA sequences upstream of inducible nodulation genes. 1988 Genes Dev. pmid:3288541
Hayashi T et al. A cytotoxic flavone from Scoparia dulcis L. 1988 Chem. Pharm. Bull. pmid:3246045
Abbiati GA et al. Receptor binding studies of the flavone, REC 15/2053, and other bladder spasmolytics. 1988 Pharm. Res. pmid:3247311
Wiltrout RH et al. Flavone-8-acetic acid augments systemic natural killer cell activity and synergizes with IL-2 for treatment of murine renal cancer. 1988 J. Immunol. pmid:3258894
Rabinovitz M The structure of flavone-8-acetic acid, a chemotherapeutic agent, and its application to drug design. 1988 J. Enzym. Inhib. pmid:3236069
Robbins RC Flavones in citrus exhibit antiadhesive action on platelets. 1988 Int J Vitam Nutr Res pmid:3243696
Armitage JP et al. Comparison of the chemotactic behaviour of Rhizobium leguminosarum with and without the nodulation plasmid. 1988 Mol. Microbiol. pmid:3210967
Lee DW and Park KH Testosterone metabolism by microsomal cytochrome P-450 in liver of rats treated with some inducers. 1989 Int. J. Biochem. pmid:2502444
Ferrari F et al. Structures of three new flavone derivatives, brosimones G, H, and I, from Brosimopsis oblongifolia. 1989 Planta Med. pmid:17262259
Hirano T et al. Effects of synthetic and naturally occurring flavonoids on Na+,K+-ATPase: aspects of the structure-activity relationship and action mechanism. 1989 Life Sci. pmid:2552245
Cummings J and Smyth JF Flavone 8-acetic acid: our current understanding of its mechanism of action in solid tumours. 1989 Cancer Chemother. Pharmacol. pmid:2667786
Kerr DJ and Kaye SB Flavone acetic acid--preclinical and clinical activity. 1989 Eur J Cancer Clin Oncol pmid:2680512
Bonnay M et al. [Flavone acetic acid and LY 186641 interfere in various ways in Jaffé's reaction]. 1989 Bull Cancer pmid:2620109
Tranchand B et al. [Phase I pharmacokinetics of flavone-acetic acid]. 1989 Bull Cancer pmid:2620114
Hill S et al. Vascular collapse after flavone acetic acid: a possible mechanism of its anti-tumour action. 1989 Eur J Cancer Clin Oncol pmid:2591434
Ching LM and Baguley BC Hyporesponsiveness of macrophages from C3H/HeJ (endotoxin-resistant) mice to the antitumour agent flavone acetic acid (NSC 347512). 1989 Eur J Cancer Clin Oncol pmid:2591444
Chabot GG et al. Pharmacodynamics and causes of dose-dependent pharmacokinetics of flavone-8-acetic acid (LM-975; NSC-347512) in mice. 1989 Cancer Chemother. Pharmacol. pmid:2597279
Ching LM and Baguley BC Reduction of cytotoxic effector cell activity in colon 38 tumours following treatment with flavone acetic acid. 1989 Eur J Cancer Clin Oncol pmid:2597283
Baguley BC et al. Comparison of the effects of flavone acetic acid, fostriecin, homoharringtonine and tumour necrosis factor alpha on colon 38 tumours in mice. 1989 Eur J Cancer Clin Oncol pmid:2702981
Lewis CR et al. Autonomic neuropathy following treatment with flavone acetic acid. 1989 Eur J Cancer Clin Oncol pmid:2703010
Nagai T et al. Inhibition of mouse liver sialidase by plant flavonoids. 1989 Biochem. Biophys. Res. Commun. pmid:2775264
Sun JR and Brown JM Enhancement of the antitumor effect of flavone acetic acid by the bioreductive cytotoxic drug SR 4233 in a murine carcinoma. 1989 Cancer Res. pmid:2790784
Cassidy J et al. Could interspecies differences in the protein binding of flavone acetic acid contribute to the failure to predict lack of efficacy in patients? 1989 Cancer Chemother. Pharmacol. pmid:2713962
Ertan R et al. Synthesis of new annellated flavonoid derivatives possessing spasmolytic activity--VII. 1989 Arch. Pharm. (Weinheim) pmid:2751412
Chabot GG et al. Flavone acetic acid (LM-975; NSC-347512) activation to cytotoxic species in vivo and in vitro. 1989 Cancer Chemother. Pharmacol. pmid:2758556
Cummings J et al. Characterization of the major metabolites of flavone acetic acid and comparison of their disposition in humans and mice. 1989 Cancer Res. pmid:2731178
Bibby MC et al. Influence of site on the chemosensitivity of transplantable murine colon tumours to flavone acetic acid (LM975, NSC 347512). 1989 Cancer Chemother. Pharmacol. pmid:2731316
Rabinovitz M Flavone-8-acetic acid and the natural flavonoids. 1989 J. Natl. Cancer Inst. pmid:2733041
Zwi LJ et al. Blood flow failure as a major determinant in the antitumor action of flavone acetic acid. 1989 J. Natl. Cancer Inst. pmid:2733044
Roy D and Liehr JG Metabolic oxidation of diethylstilbestrol to diethylstilbestrol-4',4"-quinone in Syrian hamsters. 1989 Carcinogenesis pmid:2736717
Ching LM and Baguley BC Effect of flavone acetic acid (NSC 347,512) on splenic cytotoxic effector cells and their role in tumour necrosis. 1989 Eur J Cancer Clin Oncol pmid:2737219
Atwell GJ et al. Synthesis and anti-tumour activity of topologically-related analogues of flavoneacetic acid. 1989 Anticancer Drug Des. pmid:2803464
Kerr DJ et al. Phase II trials of flavone acetic acid in advanced malignant melanoma and colorectal carcinoma. 1989 Br. J. Cancer pmid:2803908
Murray JC et al. Flavone acetic acid induces a coagulopathy in mice. 1989 Br. J. Cancer pmid:2803949
Relling MV et al. Anticancer drugs as inhibitors of two polymorphic cytochrome P450 enzymes, debrisoquin and mephenytoin hydroxylase, in human liver microsomes. 1989 Cancer Res. pmid:2908853
Wu ES et al. Flavones. 2. Synthesis and structure-activity relationship of flavodilol and its analogues, a novel class of antihypertensive agents with catecholamine depleting properties. 1989 J. Med. Chem. pmid:2909730
Bibby MC et al. Reduction of tumor blood flow by flavone acetic acid: a possible component of therapy. 1989 J. Natl. Cancer Inst. pmid:2911084
Lonchampt M et al. Protective effect of a purified flavonoid fraction against reactive oxygen radicals. In vivo and in vitro study. 1989 Arzneimittelforschung pmid:2818676
Desoize B et al. Response of primary tumour, spontaneous metastases and recurrence of Lewis lung carcinoma (3LL) to flavone acetic acid (FAA, LM975). 1989 Nov-Dec Anticancer Res. pmid:2627123
Morita K et al. Stimulatory actions of bioflavonoids on tyrosine uptake into cultured bovine adrenal chromaffin cells. 1990 Biochem. Biophys. Res. Commun. pmid:1977385
Ibrahim AR and Abul-Hajj YJ Microbiological transformation of flavone and isoflavone. 1990 Xenobiotica pmid:2346033
Liu H and Wehmeyer KR Solid-phase extraction with supercritical fluid elution as a sample preparation technique for the ultratrace analysis of flavone in blood plasma. 1992 J. Chromatogr. pmid:1400746
Le Bon AM et al. Inhibition of microsome-mediated binding of benzo[a]pyrene to DNA by flavonoids either in vitro or after dietary administration to rats. 1992 Chem. Biol. Interact. pmid:1643669
Siess MH et al. Dietary modification of drug-metabolizing enzyme activities: dose-response effect of flavonoids. 1992 J Toxicol Environ Health pmid:1602520
Minagawa N et al. Possible involvement of superoxide anion in the induction of cyanide-resistant respiration in Hansenula anomala. 1992 FEBS Lett. pmid:1318225
Barrellier MT [Lymphedema: is there a treatment?]. 1992 Jan-Feb Rev Med Interne pmid:1410875
Monici M et al. Flavone photoreactivity. UV-induced reactions in organic solvents and micellar systems. 1993 J. Photochem. Photobiol. B, Biol. pmid:8271117
Valenti P et al. Benzo-gamma-pyrone analogues of geiparvarin: synthesis and biological evaluation against B16 melanoma cells. 1993 Anticancer Drug Des. pmid:8251042
Liu H and Wehmeyer KR Supercritical fluid extraction as a sample preparation technique for the direct isolation of drugs from plasma prior to analysis. 1994 J. Chromatogr. B, Biomed. Appl. pmid:7952070
Ching LM et al. Induction of tumor necrosis factor-alpha messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488). 1994 Cancer Res. pmid:8313372
Tamura M et al. Effects of flavonoid compounds on the activity of NADPH diaphorase prepared from the mouse brain. 1994 Jpn. J. Pharmacol. pmid:7990275
Nijhoff WA et al. Enhancement of rat hepatic and gastrointestinal glutathione and glutathione S-transferases by alpha-angelicalactone and flavone. 1995 Carcinogenesis pmid:7697820
Shin W et al. Structure-taste correlations in sweet dihydrochalcone, sweet dihydroisocoumarin, and bitter flavone compounds. 1995 J. Med. Chem. pmid:7473560
Canivenc-Lavier MC et al. Comparative effects of flavonoids and model inducers on drug-metabolizing enzymes in rat liver. 1996 Toxicology pmid:8931757
Chaumontet C et al. Lack of tumor-promoting effects of flavonoids: studies on rat liver preneoplastic foci and on in vivo and in vitro gap junctional intercellular communication. 1996 Nutr Cancer pmid:8910908
Karton Y et al. Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. 1996 J. Med. Chem. pmid:8691424
Critchfield JW et al. Inhibition of HIV activation in latently infected cells by flavonoid compounds. 1996 AIDS Res. Hum. Retroviruses pmid:8825617
Siess MH et al. Time course of induction of rat hepatic drug-metabolizing enzyme activities following dietary administration of flavonoids. 1996 J Toxicol Environ Health pmid:8968409
Ji XD et al. Interactions of flavonoids and other phytochemicals with adenosine receptors. 1996 J. Med. Chem. pmid:8576921
Collins BM et al. The estrogenic and antiestrogenic activities of phytochemicals with the human estrogen receptor expressed in yeast. 1997 Steroids pmid:9090797
Hollman PC and Katan MB Absorption, metabolism and health effects of dietary flavonoids in man. 1997 Biomed. Pharmacother. pmid:9436520
Harlow GR and Halpert JR Alanine-scanning mutagenesis of a putative substrate recognition site in human cytochrome P450 3A4. Role of residues 210 and 211 in flavonoid activation and substrate specificity. 1997 J. Biol. Chem. pmid:9038138
Lin L et al. [A study on the quality of various species of Dalbergia]. 1997 Zhong Yao Cai pmid:12572437
Kitajima-Ihara T and Yagi T Rotenone-insensitive internal NADH-quinone oxidoreductase of Saccharomyces cerevisiae mitochondria: the enzyme expressed in Escherichia coli acts as a member of the respiratory chain in the host cells. 1998 FEBS Lett. pmid:9462835
Kuo SM Transepithelial transport and accumulation of flavone in human intestinal Caco-2 cells. 1998 Life Sci. pmid:9877222
Zhai S et al. Inhibition of methoxyresorufin demethylase activity by flavonoids in human liver microsomes. 1998 Life Sci. pmid:9718089
Qian S and Chen L [Studies on the chemical constituents of Citrus reticulata]. 1998 Zhong Yao Cai pmid:12567525
Belinky PA et al. The antioxidative effects of the isoflavan glabridin on endogenous constituents of LDL during its oxidation. 1998 Atherosclerosis pmid:9568736
Bai F et al. Promoter activation and following induction of the p21/WAF1 gene by flavone is involved in G1 phase arrest in A549 lung adenocarcinoma cells. 1998 FEBS Lett. pmid:9804172
Carvalho JC et al. Anti-inflammatory activity of flavone and some of its derivates from Virola michelli Heckel. 1999 J Ethnopharmacol pmid:10197753
Houghten RA et al. Mixture-based synthetic combinatorial libraries. 1999 J. Med. Chem. pmid:10508425
Reiners JJ et al. Suppression of cell cycle progression by flavonoids: dependence on the aryl hydrocarbon receptor. 1999 Carcinogenesis pmid:10426807
Maulik SK et al. Effect of flavone in a canine model of myocardial stunning. 1999 Indian J. Exp. Biol. pmid:10783754
Huang HS et al. [Advances in the research on pharmacological actions of flavone compounds]. 2000 Zhongguo Zhong Yao Za Zhi pmid:12516448
Li Y et al. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol. 2000 Clin. Cancer Res. pmid:10656453
Mruk JS et al. Flavone-8-acetic acid (Flavonoid) profoundly reduces platelet-dependent thrombosis and vasoconstriction after deep arterial injury In vivo. 2000 Circulation pmid:10645930
Siess MH et al. Mechanisms involved in the chemoprevention of flavonoids. 2000 Biofactors pmid:11216486